Educational Sessions
Autoimmune Haematology: Learning Through Cases
ESID-EHA-SIOPe 2025: Call for Clinical Case Submissions: Educational Sessions
We are excited to invite you to contribute to the Educational Sessions entitled on Autoimmune Hematology and Beyond. This dynamic and interactive event will feature one clinical case presentation selected through an open call, followed by expert analysis and audience engagement to foster collaborative learning.
Date: Tuesday, 18 November 2025
Time: 12:45-14:00 (Part I), 14:15-15:15 (Part II)
Key Dates
| Cases Submission Opens | Monday, 10 March 2025 |
| Cases Submission Deadline | Tuesday, 22 April 2025 midnight CEST (23:59) |
| Notifications* | End May 2025* |
*Note all efforts are made to send notification by the planned date. Should there be any delays with the selection process, a revised date will be posted here.
Why Submit?
- Gain expert feedback: Your case will be reviewed and discussed by top specialists in the field.
- Engage the audience: Our interactive format, including real-time voting, ensures lively discussions and learning opportunities.
- Showcase your work: Present to a community of peers and experts passionate about advancing the understanding of autoimmune hematology.
Submission Deadline
Please submit your case by Tuesday, 22 April 2025.
How to Submit?
Required documents:
- Case presentation, max 5 Powerpoint slides in a pdf format
- Curriculum Vitae
*Submission by Early Career delegates (i.e., individuals under the age of 40 years) only.
We look forward to your contributions to making this a thought-provoking and enriching experience for all attendees!
Submission Guidelines
We are seeking concise, compelling clinical cases that highlight challenges and insights in:
- Benign/Malignant lymphoproliferation
- Treatment strategies in autoimmune hematology
- Diagnostics across hematology, immunology, and histopathology
Your case should describe a patient with ALPID (defined as PMID: 37977527). To allow a thorough educational discussion, the patient should ideally have experienced autoimmune cytopenia and lymphoproliferation, with or without malignancy, during their disease. Cases with a genetic diagnosis and complete investigations including histopathological data will receive higher scores. The presenter has the responsibility of obtaining from the patient appropriate informed consent for the presentation of the clinical data as per applicable law and regulations.
Each selected presenter will have 5-10 minutes to introduce their case, followed by in-depth analysis and discussion facilitated by leading experts. At the end of the session, the presenter will have further 5-10 minutes to conclude the case putting into practice the elements discussed during the session.